| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2caaba601fd6460c7b37706d920d42e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2014-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e187ed74345d8b181d940c0897023f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_016a595573922a22aead00af4e32e5bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dbafd35b601f24e1f162978d5acf7b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_362ea4124c7ebf0e0d57999af2cb6ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7f366dd8152faa5bc4f6ad4e0c326a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4acd5d2aa757b1be179646a15620241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba7ab3c67b227cf152809064312e9ef9 |
| publicationDate |
2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9114083-B2 |
| titleOfInvention |
Granules for pharmaceutical preparations, methods and apparatus for their production |
| abstract |
Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially useful for making granules for solid oral dose pharmaceutical preparations, and are particularly suited to the production of granules comprising 5-aminosalicylic acid (5-ASA) for the treatment of inflammatory bowel disease. The granules exhibit a more sharply peaked length distribution, and hence aspect ratio distribution, and have a consequently much sharper dissolution profile after further processing. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2667637-C1 |
| priorityDate |
2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |